SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
622Y's Therapeutics and Abmaxis Announce Antibody Collaboration Tuesday March 2Icebrg-3/2/2004
621DOMANTIS RAISES US$33 (£17.5) MILLION IN SERIES B FINANCING Funding Suppornigel bates-2/23/2004
620>> which allows humanisation of the glycosylation pattern << just sscaram(o)uche-2/18/2004
619Morphotek Inc. Closes $26 Million Series C Financing Wednesday February 18, 7:02nigel bates-2/18/2004
618The moss bioreactor Jason Halm posted to the Biotech news thread: Message 1981Icebrg-2/17/2004
617(Just parking) BioInvent Announces Cross-license of Antibody Technologies with nigel bates-2/10/2004
616Abbott Laboratories and Raven biotechnologies Establish Research Collaboration FIcebrg-2/3/2004
615GPC Biotech Extends License On MorphoSys HuCal Antibodies Wednesday January 28, Icebrg-1/28/2004
614IMMU Announced that it has received a patent covering a humanized antibody to CEJibacoa-1/15/2004
613>> like most pharma sites, it appears virtually useless for research purposcaram(o)uche-1/13/2004
612Thanks for the Bayer stuff. I had a look at the website, but like most pharma sinigel bates-1/13/2004
611I worked briefly with Dr. Cho ("Sam") when we were getting the "pscaram(o)uche-1/13/2004
610Xencor and Protein Design Labs Initiate Partnership for Optimized Antibodies MonIcebrg-1/12/2004
609Seattle Genetics Announces Expansion of ADC Collaboration with Protein Design LaIcebrg-1/12/2004
608Nope. We'll see. (eom)scaram(o)uche-1/12/2004
607KaloBios and Celscia Therapeutics Announce Merger Merger Creates Human Antibodynigel bates-1/12/2004
606Ouch. I'm sorry. On a more cynical note, any idea of what happens to the Inigel bates-1/12/2004
605EpiCyte (Plantibodies) goes belly-up. The initial business plan had nothing to scaram(o)uche-1/10/2004
604Diversa and Xoma. Diversa seems eager to cover as many bases as possible. Just Icebrg-1/6/2004
603Thanks. (I keep getting the urge to buy a few XOMA, but in the past have alwaysnigel bates-1/6/2004
602I followed Ingene (acquired 1989) closely, as the founders were friends and one scaram(o)uche-1/6/2004
601XOMA / Diversa antibody deal: Message 19658541 (As an aside, does anyone know onigel bates-1/6/2004
600Design of multivalent complexes using the barnase·barstar module Sergey M nigel bates-12/31/2003
599Fluorobodies combine GFP fluorescence with the binding characteristics of antibonigel bates-12/31/2003
598<i>royalties on future sales...</i> To come out of CAT's share nigel bates-12/23/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News